Measles-associated encephalopathy in children with renal transplants

American Journal of Transplantation

Volumn 6, Issue 6, 2006, Pages 1459-1465

  Turner, A ^a,b   Jeyaratnam, D ^a   Haworth, F ^a,c   Sinha, M D ^a   Hughes, E ^a   Cohen, B ^d   Jin, L ^d   Kidd, I M ^a   Rigden, S P A ^a   MacMahon, E ^a,e  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b East Suffolk and North Essex Foundation Trust   (United Kingdom)

^c KING S MILL HOSPITAL   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Encephalitis; Encephalopathy; Kidney transplantation; Measles; Pediatric; Ribavirin; Transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MEASLES MUMPS RUBELLA VACCINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RIBAVIRIN; THYMOCYTE ANTIBODY; VIRUS RNA;

ADOLESCENT; ARTICLE; BRAIN BIOPSY; BRAIN DAMAGE; BRAIN DISEASE; CASE REPORT; CHILD; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL FEATURE; CONGENITAL NEPHROTIC SYNDROME; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MEASLES; MEASLES VIRUS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SURVIVAL; VACCINATION;

ADOLESCENT; BIOPSY; BRAIN; CHILD; HUMANS; INFANT; KIDNEY TRANSPLANTATION; MEASLES; MEASLES-MUMPS-RUBELLA VACCINE; SUBACUTE SCLEROSING PANENCEPHALITIS; TREATMENT OUTCOME;

EID: 33745817482     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01330.x     Document Type: Article

References (18)

1. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Measles, mumps and rubella - Vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps. MMWR Morb Mortal Wkly Rep Recomm Rep 1998; 47: 1-48.
2. Health Protection Agency. Indications and dosage for normal and specific immunoglobulin preparations issued by the Health Protection Agency. In: Immunoglobulin Handbook. Revised Ed. [Online]. 2004 [cited 2004 Jul 12];[28 screens]. Available from: URL: http://www.hpa.org.uk/infections/topics_az/ immunoglobulin/pdfs/ig_handbook120704.pdf
3. Hutchins SS, Papania MJ, Amler R et al. Evaluation of the measles clinical case definition. J Infect Dis 2004; 189(Suppl 1): S153-S159.
4. Mustafa MM, Weitman SD, Winick NJ, Bellini WJ, Timmons CF, Siegel JD. Subacute measles encephalitis in the young immunocompromised host: Report of two cases diagnosed by polymerase chain reaction and treated with Ribavirin and review of the literature. Clin Infect Dis 1993; 16: 654-660.
5. Kaplan LJ, Daum RS, Smaron M, McCarthy CA. Severe measles in immunocompromised patients. JAMA 1992; 267: 1237-1241.
6. Health Protection Agency. Laboratory confirmed cases of measles, mumps, and rubella, England and Wales: April to June 2003. Commun Dis Rep CDR Wkly [serial online] 2003 [cited 2003 Sept 25]; 13(39): [21 screens]. Available from: URL: http://www.hpa.org.uk/cdr/archives/2003/cdr3903.pdf
7. Cock HR, Shorvon SD. The spectrum of epilepsy and movement disorders in EPC. In: Guerrini R, Aicardi J, Andermann F, Hallett M, eds. Epilepsy and Movement Disorders. Cambridge: Cambridge University Press, 2002: 211-226.
8. Agamanolis DP, Tan JS, Parker DL. Immunosuppressive measles encephalitis in a patient with a renal transplant. Arch Neurol 1979; 36: 686-690.
9. Klapper PE, Cleator GM, Clarke MC, Postlethwaite RJ. Measles immunization. Arch Dis Child 1991; 66: 369.
10. Kaiman S, Bakkaloglu SA, Özkaya O, Buyan N, Soylemezoglu O. Measles: A rare communicable disease in a child with renal transplantation. Pediatr Transplant 2002; 6: 432-434.
11. Schulman SL, Deforest A, Kaiser BA, Polinsky MS, Baluarte HJ. Response to measles-mumps-rubella vaccine in children on dialysis. Pediatr Nephrol 1992; 6: 187-189.
12. Laube GF, Berger C, Goetschel P, Leumann E, Neuhaus TJ. Immunization in children with chronic renal failure. Pediatr Nephrol 2002; 17: 638-642.
13. Health Protection Agency. Confirmed cases of measles by region and age: 1996-2004. 2005 [cited 2005 June 23]. Available from: URL: http://www.hpa.org. uk/infections/topics_az/measles/data_reg_age.htm
14. Jansen VA, Stollenwerk N, Jensen HJ, Ramsay ME, Edmunds WJ, Rhodes CJ. Measles outbreaks in a population with declining vaccine uptake. Science 2003; 301: 804.
15. Kidd IM, Booth CJ, Rigden SPA, Tong CYW, MacMahon EM. Measles-associated encephalitis in children with renal transplants: A predictable effect of waning herd immunity? Lancet 2003; 362: 832.
16. Freeman AF, Jacobsohn DA, Shulman ST et al. A new complication of stem cell transplantation: Measles inclusion body encephalitis. Pediatrics 2004; 114: e657-e660.
17. Hannon F-X, Spika John J, Wassilak Steven S, Emiroglu N. Short report. WHO European Region's strategy for elimination of measles and congenital rubella infection. Euro Surveill 2003; 8: 128-129.
18. Stark K, Günther M, Schönfeld C, Tullius SG, Bienzle U. Immunizations in solid-organ transplant recipients. Lancet 2002; 359: 957-965.